Found: 284
Select item for more details and to access through your institution.
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 8, p. 5340, doi. 10.1245/s10434-024-15293-x
- By:
- Publication type:
- Article
The genetic evolution of acral melanoma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50233-z
- By:
- Publication type:
- Article
Post-Excision Soft X-Ray Radiotherapy for Keloids: Experience in a Tertiary Referral Center.
- Published in:
- Dermatology (10188665), 2024, v. 240, n. 4, p. 572, doi. 10.1159/000539782
- By:
- Publication type:
- Article
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1408586
- By:
- Publication type:
- Article
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1346502
- By:
- Publication type:
- Article
Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers – a randomized controlled study.
- Published in:
- BMC Palliative Care, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12904-024-01408-4
- By:
- Publication type:
- Article
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 854, doi. 10.3390/cancers16050854
- By:
- Publication type:
- Article
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 11, p. 1, doi. 10.15252/emmm.202317761
- By:
- Publication type:
- Article
What Is New in Cutaneous T Cell Lymphoma?
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 11, p. 1397, doi. 10.1007/s11912-023-01464-8
- By:
- Publication type:
- Article
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04607-4
- By:
- Publication type:
- Article
The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04391-1
- By:
- Publication type:
- Article
Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3818, doi. 10.3390/cancers15153818
- By:
- Publication type:
- Article
Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor‐related myocarditis and myositis: rechallenge?
- Published in:
- ESC Heart Failure, 2023, v. 10, n. 4, p. 2680, doi. 10.1002/ehf2.14360
- By:
- Publication type:
- Article
Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5645, doi. 10.1007/s00432-022-04514-z
- By:
- Publication type:
- Article
Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3430, doi. 10.3390/cancers15133430
- By:
- Publication type:
- Article
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 7, p. 935, doi. 10.3390/ph16070935
- By:
- Publication type:
- Article
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 6, p. 609, doi. 10.1007/s11912-023-01385-6
- By:
- Publication type:
- Article
mRNA‐COVID‐19‐Impfstoff‐induzierte Recall‐Dermatitis nach topischem Imiquimod.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 6, p. 659, doi. 10.1111/ddg.15036_g
- By:
- Publication type:
- Article
mRNA COVID 19 vaccine‐induced recall dermatitis after topical imiquimod.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 6, p. 659, doi. 10.1111/ddg.15036
- By:
- Publication type:
- Article
Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapy.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 5, p. 707, doi. 10.1111/exd.14717
- By:
- Publication type:
- Article
Real‐world outcomes using PD‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 894, doi. 10.1111/jdv.18779
- By:
- Publication type:
- Article
The impact of the COVID‐19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 922, doi. 10.1111/jdv.18953
- By:
- Publication type:
- Article
Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 877, doi. 10.3390/cancers15030877
- By:
- Publication type:
- Article
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
- Published in:
- Dermatology (10188665), 2023, v. 239, n. 1, p. 122, doi. 10.1159/000526478
- By:
- Publication type:
- Article
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7 , 5.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Triple Combination of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in BRAF V600 Melanoma: Current Status and Future Perspectives.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5489, doi. 10.3390/cancers14225489
- By:
- Publication type:
- Article
Phase 2 Study of Cemiplimab in Patients with Locally Advanced Basal-Cell Carcinoma After Hedgehog Inhibitor Therapy: Long-Term Follow-Up.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 386
- By:
- Publication type:
- Article
The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4158, doi. 10.3390/cancers14174158
- By:
- Publication type:
- Article
Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 5, p. 967, doi. 10.1159/000522053
- By:
- Publication type:
- Article
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Adultes Xanthogranulom mit LMNA‐NTRK1‐Genfusion – ein möglicher Proliferationsfaktor.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2022, v. 20, n. 9, p. 1231, doi. 10.1111/ddg.14848_g
- By:
- Publication type:
- Article
Adult xanthogranuloma with LMNA‐NTRK1 gene fusion – a possible driver of proliferation.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2022, v. 20, n. 9, p. 1231, doi. 10.1111/ddg.14848
- By:
- Publication type:
- Article
Targeted Long-Read Bisulfite Sequencing Identifies Differences in the TERT Promoter Methylation Profiles between TERT Wild-Type and TERT Mutant Cancer Cells.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 4018, doi. 10.3390/cancers14164018
- By:
- Publication type:
- Article
Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3829, doi. 10.3390/cancers14153829
- By:
- Publication type:
- Article
Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 2021, 13 , 3830.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Identification and characterization of novel CD274 (PD‐L1) regulating microRNAs and their functional relevance in melanoma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.934
- By:
- Publication type:
- Article
Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.861545
- By:
- Publication type:
- Article
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2360, doi. 10.3390/cancers14102360
- By:
- Publication type:
- Article
Eight Years of Real-Life Experience with Smoothened Inhibitors in a Swiss Tertiary Skin Referral Center.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2496, doi. 10.3390/cancers14102496
- By:
- Publication type:
- Article
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092300
- By:
- Publication type:
- Article
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.830627
- By:
- Publication type:
- Article
A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans.
- Published in:
- PLoS Biology, 2022, v. 20, n. 2, p. 1, doi. 10.1371/journal.pbio.3001317
- By:
- Publication type:
- Article
Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2225, doi. 10.1007/s13555-021-00619-4
- By:
- Publication type:
- Article
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [<sup>18</sup>F]FDG PET/CT.
- Published in:
- European Radiology, 2021, v. 31, n. 10, p. 8011, doi. 10.1007/s00330-021-07852-7
- By:
- Publication type:
- Article
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25326-8
- By:
- Publication type:
- Article
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3830, doi. 10.3390/cancers13153830
- By:
- Publication type:
- Article